arrow
V

Vikram V. Holla

national institute of mental health and neurosciences
H指数:15
被引数:1,196

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ayurvedic Therapeutic Regimen as an Add-On to Optimized Conventional Management of Parkinson Disease: Protocol for an Exploratory Randomized Controlled Trial Evaluating Clinical, Cortical Excitability, Neuroimmune, and Autonomic Function Parameters

阿育吠陀疗法作为帕金森病优化常规管理的附加疗法:一项探索性随机对照试验方案,评估临床、皮质兴奋性、神经免疫和自主功能参数

2026-01-010
PRE
Current Perspectives and Practices in Infection-Related Movement Disorders (IRMD): Insights from a Survey of Members of the International Parkinson and Movement Disorder Society

感染相关性运动障碍(IRMD)的当前观点与实践:国际帕金森病与运动障碍学会会员调查的见解

2025-09-010
PRE
Unstable FGF14 GAA repeat expansions in Indian ataxia patients: a broader phenotype and involvement of modifier loci?

印度共济失调患者中不稳定的FGF14 GAA重复扩展:更广泛的表型及修饰位点的参与?

2025-08-200
PRE
Temporal onset of non-motor symptoms and the body-first/brain-first dichotomy in Parkinson’s disease: a cross-sectional single center experience

帕金森病非运动症状的发作时间及身体优先/大脑优先二分法:一项横断面单中心研究经验

2025-08-120
PRE
White matter alterations in tremor-dominant and postural instability and gait disturbance subtypes of Parkinson’s disease

帕金森病震颤主导型和姿势不稳步态障碍亚型的白质改变

2025-08-110
PRE
Corrigendum to “MOGAD treatment outcomes and relapse characteristics: Real world experience from a Low-Middle income country” [Multiple Sclerosis and Related Disorders, Volume 100 (2025), 106548]

勘误:“MOGAD治疗结局与复发特征:来自中低收入国家的真实世界经验” [多发性硬化与相关疾病,卷100(2025),106548]

2025-07-170
PRE